Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Lipoprotein lipase (LPL) is a key regulator of triglyceride clearance. Its coordinated regulation during feeding and fasting is critical for maintaining lipid homeostasis and energy supply. Angiopoietin-like (Angptl)3 and Angptl4 are secreted proteins that have been demonstrated to regulate triglyceride metabolism by inhibiting LPL. We have taken a targeted genetic approach to generate Angptl4- and Angptl3-deficient mice as well as transgenic mice overexpressing human Angptl4 in the liver. The Angptl4 transgenic mice displayed elevated plasma triglycerides and reduced postheparin plasma (PHP) LPL activity. A purified recombinant Angptl4 protein inhibited mouse LPL and recombinant human LPL activity in vitro. In contrast to the transgenic mice, Angptl4-deficient mice displayed hypotriglyceridemia and increased PHP LPL activity, with greater effects in the fasted compared with the fed state. Angptl3-deficient mice also displayed hypotriglyceridemia with elevated PHP LPL activity, but these mice showed a greater effect in the fed state. Mice deficient in both Angptl proteins showed an additive effect on plasma triglycerides and did not survive past 2 months of age. Our results show that Angptl3 and Angptl4 function to regulate circulating triglyceride levels during different nutritional states and therefore play a role in lipid metabolism during feeding/fasting through differential inhibition of LPL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ANGPTL3 inhibits the lipoprotein lipase, which results in increased blood lipid levels [143–145].”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“Evinacumab is a monoclonal antibody inhibiting angiopoietin-like 3 (ANGPTL3).”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“In contrast to other pharmacological treatments, evinacumab’s MoA is therefore independent of the LDL-C receptor [143, 148], providing new options for more synergistic combination treatments.”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“Thus, Angptl4 knockout mice have reduced plasma triglycerides, whereas Angptl4 overexpressing mice have increased triglyceride levels [9,10].”
From Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity (2015) · cites this paper as [9]
In the citing paper
“Conversely, ANGPTL4-deficient mice had lower than normal plasma triglycerides and higher postheparin-plasma LPL activity (16).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [16]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., & Wahli, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004029200 · Cited by 489
Angptl3 regulates lipid metabolism in mice
Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., & Furukawa, H. (2002) · Nature Genetics · doi:10.1038/ng814 · Cited by 379
Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y., Soukas, A., Friedman, J. M., Holmes, W. E., & Spiegelman, B. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5343-5349.2000 · Cited by 356
Shimizugawa, T., Ono, M., Shimamura, M., Yoshida, K., Ando, Y., Koishi, R., Ueda, K., Inaba, T., Minekura, H., Kohama, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203215200 · Cited by 339
Yoshida, K., Shimizugawa, T., Ono, M., & Furukawa, H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200010-jlr200 · Cited by 317
Kim, I., Kim, H.-G., Kim, H. W., Kim, H.-H., Park, S. K., Uhm, C.-S., Lee, Z. H., & Koh, G. Y. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460603 · Cited by 284
Weinstock, P. H., Bisgaier, C. L., Aalto-Setälä, K., Radner, H., Ramakrishnan, R., Levak-Frank, S., Essenburg, A. D., Zechner, R., & Breslow, J. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118319 · Cited by 254
Cited by
Items 301–400 of 427
The cytokine FAM3B/PANDER is an FGFR ligand that promotes posterior development in Xenopus
Zhang, F., Zhu, X., Wang, P., He, Q., Huang, H., Zheng, T., Li, Y., Jia, H., Xu, L., Zhao, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100342118 · Cited by 14
“Another case is that of angiopoietin-like 4 (Angptl4), a secreted protein that promotes notochord formation by antagonizing Wnt signaling in Xenopus , yet regulates tri-glyceride metabolism in mutant mice (49 – 51).”
Anti-PCSK9 treatment: is ultra-low low-density lipoprotein cholesterol always good?
Noto, D., Giammanco, A., Barbagallo, C. M., Cefalu, A. B., & Averna, M. R. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy144 · Cited by 12
Li, G., Zhang, H., & Ryan, A. S. (2020) · Metabolites · doi:10.3390/metabo10090354 · Cited by 9
Adaptive Ridge Regression for Rare Variant Detection
Zhan, H., & Xu, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044173 · Cited by 11
A long journey to effective obesity treatments: is there light at the end of the tunnel?
Dodson, M. V., Boudina, S., Albrecht, E., Bucci, L. R., Culver, M. F., Wei, S., Bergen, W. G., Amaral, A. J., Moustaïd‐Moussa, N., Poulos, S. P., et al. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213477603 · Cited by 13
Is there a link between proprotein convertase PC7 activity and human lipid homeostasis?
Guillemot, J., Essalmani, R., Hamelin, J., & Seidah, N. G. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.08.004 · Cited by 13
“We also analyzed the processing of apolipoprotein F (apoF) and angiopoietin-like 4 (ANGPTL4) implicated in HDL and/ or triglyceride metabolism [22,23].”
MethodHepatic PGC-1α is not essential for fasting-induced cytochrome p450 regulation in mouse liver
Thøgersen, R., Kristensen, C. M., Olsen, M. A., Bertram, H. C., Pilegaard, H., & Rasmussen, M. K. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113736 · Cited by 9
Angiopoietin-like protein 4 regulates breast muscle lipid metabolism in broilers
Zhao, X., Huang, H., Ding, X. L., Yang, Z., Hou, Y., & Wang, H. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101159 · Cited by 11
“Ge et al. (2004); K€oster et al. (2005); Lichtenstein et al. (2007) and Wang et al. (2016) reported that ANGPTL4 overexpression dramatically increased concentrations of TG and NEFA in the plasma of mice.”
BackgroundAdipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice
Ha, E. E., Quartuccia, G. I., Ling, R., Xue, C., Karikari, R. A., Hernández‐Ono, A., Hu, K. Y., Matias, C. V., Imam, R., Cui, J. G., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101412 · Cited by 11
“There is precedent that the observed increase in LPL activity in the Trib1_ASKO mice drives the decrease in plasma cholesterol, as multiple studies using transgenic Lpl animal models [47e49] or Angptl4 knockout or transgenic mice [50,51] demonstrate that increased LPL activity protects from diet-induced hypercholester…”
BackgroundNovel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4−/−Gpihbp1−/− mice
Cushing, E. M., Sylvers, K. L., Chi, X., Shetty, S. K., & Davies, B. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m084749 · Cited by 10
“ANGPTL4 deficiency leads to lower TG levels in mice and humans (11–14), and mice overexpressing ANGPTL4 have elevated TG levels (11).”
BackgroundHezarkhani, S., Hajighaderi, A., Hosseinzadeh, S., Behnampour, N., Veghari, G., Fathabadi, F., Hesari, Z., & Joshaghani, H. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.466 · Cited by 8
Kany, S., Rämö, J. T., Hou, C. R., Jurgens, S. J., Khurshid, S. S., Nauffal, V., Cunningham, J. W., Lau, E. S., Koyama, S., FinnGen, et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02397-7 · Cited by 12
“26,27).”
Xiang, X., Han, S., Xu, D., Chen, Q., Ji, R., Zhao, Z., Du, J., Mai, K., & Ai, Q. (2021) · British Journal Of Nutrition · doi:10.1017/s000711452100386x · Cited by 13
Angiopoietin-Like Proteins and Lipid Metabolism
Kersten, S. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_9 · Cited by 10
“(Koishi et al. 2002) . Conversely, adenoviral-mediated over-expression and intravenous injection of recombinant Angplt3 leads to increased plasma TGs, FFAs, and cholesterol levels ( Koishi et al. 2002 ; Shimizugawa et al. 2002) . Similar to Angptl4, the dramatic effect of Angptl3 on fasting plasma TG levels can be asc…”
BackgroundInfluentialLiu, D. J., & Leal, S. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.211 · Cited by 11
Qiao, L., Shetty, S. K., Spitler, K. M., Wattez, J.-S., Davies, B. S. J., & Shao, J. (2020) · Diabetes · doi:10.2337/db19-1181 · Cited by 9
“ANGPTL4 is the most potent LPL inhibitor in the ANGPTL family (17,20,21) and is highly expressed in white adipose tissue (WAT) and brown adipose tissue (BAT) (20,22).”
BackgroundGutiérrez-Castro, K. P., González, A. P., Caccavello, R. J., Garay‐Sevilla, M. E., & Gugliucci, A. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.12.016 · Cited by 9
Lai, D., Tu, Y., Hsieh, Y., Hsu, W., Lee, C., Cheng, W., Hsieh, F.-J., & Li, H. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21262 · Cited by 9
“In addition to their role in angiogenesis, Angptl3 and Angptl4 were also found to regulate circulating triglyceride levels through differential inhibition of lipoprotein lipase (Koster et al., 2005).”
Backgroundvan de Pas, N. C. A., Soffers, A. E. M. F., Freidig, A. P., van Ommen, B., Woutersen, R. A., Rietjens, I. M. C. M., & de Graaf, A. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.009 · Cited by 11
Biotechnology Approaches for the Treatment of Dyslipidemia
Parolini, C. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07017-6 · Cited by 10
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study
Iannuzzo, G., Calcaterra, I. L., Gentile, M., Stanzione, C., Ruberto, F. D., Taranto, M. D. D., Fortunato, G., & Minno, M. N. D. D. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03160-4 · Cited by 10
“This metabolic pathway, while not yet completely clarified, is independent of the LDL receptor and regulates the clearance of very low-density lipoproteins (VLDL) [19, 24, 25].”
Characterization of sexual dimorphism in ANGPTL4 levels and function
Deng, M., & Kersten, S. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100526 · Cited by 8
“So far, nearly all preclinical studies on ANGPTL4 have been performed in male mice, with some exceptions (25, 35 – 37).”
BackgroundGhosh, A., Chénier, I., Leung, Y. H., Oppong, A. K., Peyot, M., Madiraju, S. R. M., Al‐Khairi, I., Abubaker, J. A., Al‐Mulla, F., Prentki, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111292 · Cited by 10
“Indeed, it has been shown before that adiponectin promoter is active by embryonic day 11–16 53–55 and that A8 likely plays an important role in fetal development.”
van der Kolk, B. W., Vink, R., Jocken, J. W. E., Roumans, N. J. T., Goossens, G. H., Mariman, E. C. M., van Baak, M. A., & Blaak, E. E. (2018) · Physiological Reports · doi:10.14814/phy2.13735 · Cited by 8
Han, X., Dai, R., Zhai, Y., Shen, Q., Sun, L., Liu, H., & Xu, H. M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.065 · Cited by 8
Janssen, L. G. M., Jauhiainen, M., Olkkonen, V. M., Haridas, P. A. N., Nahon, K. J., Rensen, P. C. N., & Boon, M. R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081214 · Cited by 9
Valiakou, V., Eliadis, P., Karamichali, E., Tsitsilonis, O., Koskinas, J. S., Georgopoulou, U., & Foka, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157961 · Cited by 11
“They both increase plasma triglycerides [24,25] through posttranslational inhibition of lipoprotein lipase (LPL) and hepatic lipase (HL) enzymatic activity [26,27].”
BackgroundSchmid, A., Belikan, H., Höpfinger, A., Schäffler, A., & Karrasch, T. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02748-0 · Cited by 9
“The molecular consequence would comprise a disinhibition of LPL-mediated lipolysis and a consecutive reduction of triglycerides.”
BackgroundInfluentialJáromi, L., Csöngei, V., Polgár, N., Rappai, G., Szolnoki, Z., Maász, A., Horvatovich, K., Sáfrány, E., Sipeky, C., Magyari, L., et al. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8149-7 · Cited by 11
“Mice lacking ANGPTL3 have increased LPL activity and decreased levels of plasma triglycerides (Koishi et al. 2002; Koster et al. 2005).”
BackgroundXiao, H., Niu, X.-W., & Sun, Z.-L. (2012) · Livestock Science · doi:10.1016/j.livsci.2012.02.006 · Cited by 9
“Angptl4 can modulate triglyceride (TG) metabolism by inhibiting LPL (Köster et al., 2005; Shimizugawa et al., 2002).”
BackgroundDahlhoff, M., Camera, E., Picardo, M., Zouboulis, C. C., & Schneider, M. R. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.04.008 · Cited by 8
Seely, E. W., & Grinspoon, S. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00002-8 · Cited by 11
Increased plasma lipoprotein lipase activity in males with autism spectrum disorder
Hirai, T., Usui, N., Iwata, K., Miyachi, T., Tsuchiya, K. J., Xie, M.-J., Nakamura, K., Tsujii, M., Sugiyama, T., & Matsuzaki, H. (2020) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2020.101630 · Cited by 7
The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
Richter, M. M., & Plomgaard, P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab121 · Cited by 7
“Other signaling molecules, including follistatin and angiopoietinlike 4 (ANGPTL4), were later demonstrated to be liverderived in humans [11, 12] and implicated in metabolism [13-16].”
BackgroundYang, S., Su, X., Lai, M., Liu, X., & Cheng, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25862 · Cited by 8
“Specifically, ANGPTL3 is dominant under feed conditions, whereas ANGPTL4 plays a greater function under fasting conditions [54].”
Effects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki Rats
Nie, J., DuBois, D. C., Xue, B., Jusko, W. J., & Almon, R. R. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017710009 · Cited by 8
Nolte, W., Weikard, R., Albrecht, E., Hammon, H. M., & Kühn, C. (2021) · Genomics · doi:10.1016/j.ygeno.2021.12.004 · Cited by 7
Differential Effects of Bariatric Surgery on Plasma Levels of ANGPTL3 and ANGPTL4.
Bini, S., D’Erasmo, L., Astiarraga, B., Minicocci, I., Palumbo, M., Pecce, V., Polito, L., Costanzo, A. D., Haeusler, R. A., Arca, M., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.08.019 · Cited by 7
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance
Gomes, D. B. R., Sobolewski, C., Conzelmann, S., Schaer, T., Lefai, É., Alfaiate, D., Tseligka, E. D., Goossens, N., Tapparel, C., Negro, F., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33728-5 · Cited by 8
Angiopoietin-like peptide 4 regulates insulin secretion and islet morphology
Kim, H.-K., Kwon, O., Park, K.-H., Lee, K. J., Youn, B., Kim, S., & Kim, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.031 · Cited by 7
Lipid metabolic features of skeletal muscle in pathological and physiological conditions
Son, Y., & Paton, C. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00018-x · Cited by 8
Peng, Y., Hu, D., Luo, Q., & Peng, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863687 · Cited by 6
Liu, Q., Lv, Y., Qiu, W., Huang, L., & Li, Y. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221219123937 · Cited by 6
Ortega, H., Schaefer-Graf, U. M., Meitzner, K., Graf, K., Abou‐Dakn, M., & Herrera, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081201 · Cited by 6
“The main role attributed to ANGPTL4 has been its action as an inhibitor of lipoprotein lipase [12–14]; indeed, in mice, overexpression of ANGPTL4 does cause hypertriacylglycerolemia [15] and inactivation of its gene results in hypotriacylglycerolemia [12,13].”
BackgroundTranscriptome Adaptation of the Ovine Mammary Gland to Dietary Supplementation of Extruded Linseed
Conte, G., Giordani, T., Vangelisti, A., Serra, A., Pauselli, M., Cavallini, A., & Mele, M. L. (2021) · Animals · doi:10.3390/ani11092707 · Cited by 8
“Moreover, it was shown in transgenic mice that ANGPTL3 and ANGPTL4 regulated circulating triglyceride levels under different nutritional regimes and thus play roles in lipid metabolism through differential inhibition of lipoprotein lipase [65].”
BackgroundANGPLT3: A novel modulator of lipid metabolism
Hassan, M. S. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.65 · Cited by 7
Herrero-Encinas, J., Corrales, N. L., Sevillano, F., Ringseis, R., Eder, K., & Menoyo, D. (2023) · Antioxidants · doi:10.3390/antiox12091751 · Cited by 6
“Despite this, among the most differentially expressed genes, angiopoietin-like 4 (ANGPTL4), which is involved in the regulation of lipoprotein lipase activity and triglyceride metabolism [55], was −2.”
Abu‐Farha, M., Alatrach, M., Abubaker, J. A., Al‐Khairi, I., Cherian, P., Agyin, K., Abdelgani, S., Norton, L., Adams, J., Alsaeed, D., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3643 · Cited by 5
Familial combined hypolipidemia due to mutations in theANGPTL3gene
Calandra, S., Tarugi, P., Averna, M. R., & Bertolini, S. (2013) · Clinical Lipidology · doi:10.2217/clp.12.92 · Cited by 5
Lenz, M. W., Schönbauer, R., Stojković, S., Lichtenauer, M., Paar, V., Gatterer, C., Schukro, C., Emich, M., Fritzer‐Szekeres, M., Strametz‐Juranek, J., et al. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04382-2 · Cited by 6
Proof of Evidence: PPAR-induced ANGPTL4 in Lipid and Glucose Metabolism
Yoshida, K. (2007) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr2007.0010 · Cited by 4
Constraint and divergence of global gene expression in the mammalian embryo
Spies, N., Smith, C. L., Rodriguez, J. M., Baker, J. C., Batzoglou, S., & Sidow, A. (2015) · eLife · doi:10.7554/elife.05538 · Cited by 5
“This hypothesis is supported by the known functions of the most significant target gene, Angptl4, which responds to lipid metabolism and energy homeostasis, and participates in angiogenesis (Koster et al., 2005; Scott et al., 2012).”
BackgroundRegulation and Clearance of Apolipoprotein B–Containing Lipoproteins
Fazio, S., & Linton, M. F. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50006-8 · Cited by 5
Liu, C., Yi, X., Lyu, Y., Ren, W., Zhou, Y., Feng, G., Wan, W., & Jiang, X. (2021) · Medical Science Monitor · doi:10.12659/msm.929626 · Cited by 4
“Similarly, ANGPTL4 is a potent LPL inhibitor, and plays an important role in regulating LPL activity.”
BackgroundGenetic risk and its role in primary prevention of CAD
Roberts, R., Chavira, J., & Venner, E. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2022.07 · Cited by 4
Human Plasma Lipoprotein Metabolism
Pownall, H. J., Rosales, C., Gillard, B. K., Moon, J. E., & Gotto, A. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00001-3 · Cited by 7
Walking the VLDL tightrope in cardiometabolic diseases
Kim, M., & Zheng, Z. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.020 · Cited by 4
Muroya, S., Ojima, K., Shimamoto, S., Sugasawa, T., & Gotoh, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157540 · Cited by 3
Yarmolinsky, J. W., Lau, E., Koskeridis, F., Gunter, M. J., Wang, D. Y. Q., Dehghan, A., & Tzoulaki, I. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322433 · Cited by 4
Yen, I., Lin, S., Lin, M., Lee, C., Kuo, C., Chen, S., Tai, Y., Kuo, C., Kuo, H., Lin, H., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117775 · Cited by 4
Genetics of Atherosclerotic Cardiovascular Disease
Qasim, A., & Reilly, M. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00061-6 · Cited by 4
Prater, M. C., Scheurell, A. R., Paton, C. M., & Cooper, J. A. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.01.006 · Cited by 3
Li, X., Li, C., Xue, W., Wei, Z., Shen, H., Wu, K., Zhu, H., Xu, H., Wu, X., Yi, H., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2337740 · Cited by 3
Tsuzaki, K., Kotani, K., Yamada, K., & Sakane, N. (2015) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21869 · Cited by 3
Lipoprotein Lipase in the Arterial Wall: Regulation by Dietary Fatty Acids
Chang, C. L. (2011) · doi:10.7916/d81r6xh3 · Cited by 5
Toroghi, M. K., Bosley, J., Powell, L. M., Zhang, Y., Yang, F., Pu, X., Davis, J. D., & Al-Huniti, N. H. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12694 · Cited by 2
Tocilizumab‐related hypertriglyceridemia is independent of key molecules regulating lipid metabolism
Ferraz‐Amaro, I., Santos‐Concepción, S., Castro‐Hernández, J., Hernández-Hernández, V., Segura, B. T., Luna, C., Delgado-Frías, E., & Díaz‐González, F. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14006 · Cited by 3
Protein signatures of feed restriction and spontaneous lipolysis in skimmed ewe milk
Delosière, M., Bernard, L., Imbert, A., Taillandier, M., Viala, D., Hurtaud, C., Larroque, H., Bonnet, M., & Cebo, C. (2025) · Journal of Dairy Science · doi:10.3168/jds.2024-26103 · Cited by 3
Zadeh, S. S. T., Toth, P. P., & Banach, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1789019 · Cited by 2
ANGPTL4/8 promotes plasmin-mediated cleavage of LPL inhibitors
Kersten, S. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100438 · Cited by 2
“ANGPTL3 was discovered as a liver-derived LPL inhibitor that is mainly active in the fed state (8, 9).”
BackgroundDistinct roles of angiopoietin-like 4 in the regulation of central and peripheral lipid metabolism?
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.003 · Cited by 3
“The strong triglyceride lowering effect seen in Angptl4 knockout mouse models [3,8] suggested this molecule as a potential target for future lipid-lowering therapies.”
Ranneh, F. H. H. A. Y. (2013) · Medicinal Chemistry · doi:10.4172/2161-0444.1000151 · Cited by 1
“Non etserified fatty acids (NEFAs) or free fatty acids (FFAs) are derived from either lipolysis of adipose tissue TG or chylomicrons of dietary fat [24-26].”
BackgroundEndogenous and exogenous factors affecting lipoprotein lipase activity
Larsson, M. (2014) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Vil trening in vivo prege skjelettmuskelceller in vitro
Lund, J. (2013) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Tissue-specific insulin resistance in human obesity: A physiological approach to lipid metabolism
van der Kolk (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180503bk · Cited by 2
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00125-0 · Cited by 2
Fang, Y., Zhang, Y., Wei, T., Akhtar, H., Song, Y., Wang, Y., Yang, M. G., Hao, R., Li, Y., Sun, Z., et al. (2025) · Environmental Science Nano · doi:10.1039/d5en00161g · Cited by 3
Yoo, J. H. (2025) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2025.7.e19 · Cited by 2
“A critical feature of ANGPTL3 is its regulation of lipid metabolism through pathways independent of the LDLR [30].”
Yoo, J.-A., Kim, Y. H., Choe, M. S., Sghayare, H., Zhang, Q., Kwon, G., Kim, Y., Lee, S.-Y., Lee, C., Sung, H., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.11.003 · Cited by 2
Zhang, D., Liu, Z., Chen, X., Kuang, G., Pan, R., & Sun, Z. (2013) · African Health Sciences · doi:10.4314/ahs.v12i4.20 · Cited by 1
Nutritional regulation of adipose tissue lipoprotein lipase is blunted in insulin resistant rats
Cahová, M., Papáčková, Z., Páleníčková, E., Daňková, H., Ždychová, J., Škop, V., & Kazdová, L. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0002-y · Cited by 1
Angiopoietin-like 4: An endogenous break of intestinal lipid digestion
Kotzbeck, P., & Zechner, R. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.009 · Cited by 1
“The Angptlprotein family consists of eight identified members (Angptl1–8) of which at least Angptl3, Angptl4, and Angptl8 affect LPL activity and plasma TAG concentrations [5,6].”
Stabilizing lipoprotein lipase
Kersten, S., & Bensadoun, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.e000703 · Cited by 2
Endothelial lipase variant T111I does not alter inhibition by angiopoietin-like proteins
Sylvers-Davie, K. L., Bierstedt, K. C., Schnieders, M. J., & Davies, B. S. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-54705-6 · Cited by 1
Kivelä, A. M., Heinonen, S. E., Leppänen, P., Dijkstra, M. H., Gurzeler, E., Huusko, J., Olkkonen, V. M., Eriksson, U., Jauhiainen, M., & Ylä‐Herttuala, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht308.p2386 · Cited by 1
Angiopoietin-like protein 4 : an unfolding chaperone regulating lipoprotein lipase activity
Sukonina, V. (2007) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Functional characterization of the PPAR targets ANGPTL4 and HILPDA in lipid metabolism
Mattijssen, F. (2014) · doi:10.18174/302873 · Cited by 1
“Isolation of RNA and subsequent analysis of gene expression by qPCR was carried out as previously described (48).”
BackgroundMethodThe Role of Angiopoietin-like 4 in Lipid Homeostasis
Gray, N. E. (2012) · eScholarship (California Digital Library) · Cited by 1
Adipocyte Tribbles1 Regulates Plasma Adiponectin and Plasma Lipids in MicePreprint
Ha, E. E., Quartuccia, G. I., Ling, R., Xue, C., Hernández‐Ono, A., Imam, R., Cui, J. G., Soni, R. K., & Bauer, R. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.11.434882 · Cited by 1
“Multiple studies using transgenic Lpl animal models 343 [30-32] as well as Angptl4 knockout or transgenic mice [33, 34] demonstrate that increased Lpl 344 activity protects from diet-induced hypercholesterolemia and decreases plasma LDL-C levels, 345 though the effects are not as robust as effects on plasma TGs.”
BackgroundMapping the diverse functions of dietary fatty acids via target gene regulation
Georgiadi, A. (2012) · doi:10.18174/210606 · Cited by 1
Mixture and Mixed Models Analysis for Genetic Variants
Zhan, H. (2013) · eScholarship (California Digital Library)
NK/NKT Cells and Atherosclerosis
Cavallari, M., Resink, T. J., & Libero, G. D. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_16 · Cited by 2
“The mouse gene has been shown as causal in a hypolipidemic mouse strain [119] and its inactivation lowered cholesterol and triglyceride levels in wild-type [120], ApoE( / ) and LDLr( / ) mice [121, 122].”
BackgroundLipid and lipoprotein metabolism, hypolipidemic agents, and therapeutic goals
Reyes‐Soffer, G., & Ginsberg, H. N. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch17 · Cited by 1
Effect of 1,3,5,8-tetrahydroxyxanthone on carcass characteristics and meat quality traits in pigs
Xiao, H., Jun, F., & Sun, Z. (2012) · Animal Production Science · doi:10.1071/an12001
“Angptl3 is exclusively expressed in the liver (Köster et al. 2005).”
BackgroundLes cellules endothéliales du tissu adipeux
Villaret, A., Walther, R., Lafontan, M., & Bouloumié, A. (2011) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2011.06.005 · Cited by 3
Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood
Nilsson, S. K. (2010)
Cenarro, A. (2008) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(08)72602-0
Familial Low-Cholesterol Syndromes or Hypobetalipoproteinemias
Noto, D., Tarugi, P., & Averna, M. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98702-6
Stéatose et résistance à l’insuline : implication des hépatokines
Bertrand, C., Valet, P., & Castan‐Laurell, I. (2015) · Obésité · doi:10.1007/s11690-015-0492-7
Metadata
- Authors
- Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., Heuer, J. G., Jaskunas, S. R., & Eacho, P.
- Affiliations
- Eli Lilly (United States) (US)
- Takeda Oncology (United States) (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-11-01
- Volume
- 146
- Issue
- 11
- Pages
- 4943-4950
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2117617326
- Semantic Scholar
- 6382419c744ba19464b065395484df9cb3cf3eaf
- Cited by
- 427
- References
- 36
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 14 · 2023: 15 · 2022: 11 · 2021: 41 · 2020: 26 · 2019: 20 · 2018: 33 · 2017: 21 · 2016: 23 · 2015: 26 · 2014: 27 · 2013: 29 · 2012: 22
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- ANGPTL4, ANGPTL3, lipoprotein lipase, triglyceride metabolism, hypotriglyceridemia, plasma triglycerides, lipoprotein lipase inhibition, fasting and feeding, lipid homeostasis, knockout mice, transgenic mice
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 4, Angiopoietin-Like Protein 3, Animals, Fasting, Heparin, Humans, Hyperlipidemias, Lipoprotein Lipase, Mice, Transgenic, Recombinant Proteins, Triglycerides, Survival Analysis, Mice, Knockout, Postprandial Period, Intercellular Signaling Peptides and Proteins, Angiopoietins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.